The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Respiratory syncytial virus and influenza activity are on the rise in parts of the country, particularly among young children, according to the CDC's latest respiratory virus updates. Overall, the ...

Researchers found that vaccine effectiveness was 80% and 81% against RSV-associated hospitalizations and against RSV-associated critical illness among 28,271 hospitalizations for RSV-like illness ...

The Australian government has said it will make vaccination against respiratory syncytial virus (RSV) free for newborns and pregnant women starting in 2025. Mark Butler, the minister for health, on ...

Big Data, Real World, Multi-State Study Finds RSV Vaccine Highly Effective in Protecting Older Adults Against Severe Disease, Hospitalization and Death Oct. 17, 2024 — This multi-state study is ...

The federal government will place RSV vaccines on the national immunisation program, as 12,000 babies are hospitalised with ...

This season, doctors have two new weapons to fight RSV. First is a vaccine. “Moms can get a vaccine against RSV when they’re ...

If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. Health officials say it’s important to ...

GlaxoSmithKline (GSK) has received approval for its vaccine, AREXVY, in Canada to prevent lower respiratory tract disease ...

The World Health Organization (WHO) on Tuesday released a new study listing 17 endemic pathogens that require vaccines urgently. The study published today in the journal eBioMedicine identifies ...

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the country's first authorized RSV shot for that age ...

A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...